Unstable Angina
📧 Sign up to get email alerts when something new happens for Unstable Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome [Phase 3]
Phase 3 trial evaluating safety and efficacy of two ticagrelor-based de-escalation antiplatelet strategies in acute coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients [Phase 2]
Phase 2 trial comparing ALX-0081 to a GPIIb/IIIa inhibitor in high-risk PCI patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Prasugrel Or Ticagrelor De-escalation in NSTE-ACS [Phase 3]
Phase 3 clinical trial update on de-escalation of prasugrel or ticagrelor in NSTEMI/NSTE-ACS patients; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial [Phase 4]
Phase 4 trial assessing strategies for treating coronary artery stenosis using next-generation drug-eluting stents and abbreviated dual anti…
-
FDA approval · 2022-06-14FDA Approved: ENOXAPARIN SODIUM — Original Application (BluePoint Laboratories)
The FDA approved BluePoint Laboratories' original ANDA for enoxaparin sodium, a low molecular weight heparin, expanding availability of its …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2022-03-17EMA Authorised: Integrilin (eptifibatide) — GlaxoSmithKline Trading Services Limited
Authorised by EMA: Integrilin (eptifibatide) approved for unstable angina and myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome [Phase 4]
A Phase 4 trial comparing low molecular weight heparin (LMWH) to rivaroxaban in Chinese patients hospitalized with acute coronary syndrome e…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Implementing Precision Medicine Approaches to Guide Anti-platelet Selection [Phase 4]
Phase 4 trial update exploring precision medicine approaches to guide anti-platelet selection in acute coronary syndrome and MI settings.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms [NA]
Clinical trial update on mindfulness-based cognitive therapy delivered via group videoconferencing for ACS patients with elevated depression…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention [Phase 2]
Phase 2 trial comparing shortened Aggrastat to Integrilin in percutaneous coronary intervention has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris [Phase 4]
Phase 4 trial update on Wen Xin Granules for unstable angina within coronary heart disease, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers [Phase 4]
A Phase 4 clinical trial comparing downstream versus upstream strategies for administering P2Y12 receptor blockers in patients with unstable…
-
FDA approval · 2020-07-17FDA Approved: CLOPIDOGREL — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approves Polygen Pharmaceuticals' original ANDA for a generic clopidogrel product.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel [Phase 2]
Phase 2 trial comparing crushed ticagrelor to eptifibatide bolus plus clopidogrel in acute coronary syndrome and unstable angina; study comp…
-
FDA approval · 2019-09-23FDA Approved: BIVALIRUDIN — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Bivalirudin submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial [Phase 4]
A Phase 4 randomized trial compares continuing versus interrupting metformin after coronary angiography in patients with acute coronary synd…
-
FDA approval · 2019-05-16FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)
The FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine [Phase 4]
A Phase 4 clinical trial evaluating how naloxone affects the pharmacokinetics and pharmacodynamics of ticagrelor in patients with unstable a…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 clinical trial assessing the effect of ticagrelor on endothelial healing after drug-eluting stent implantation in patients with ac…
-
FDA approval · 2018-09-04FDA Approved: TICAGRELOR — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva's generic ticagrelor (ANDA 208390) as an original application approval for TICAGRELOR.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds [NA]
Clinical trial update on optimal lesion preparation using non-compliant balloons before implantation of bioresorbable scaffolds in coronary …
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen [NA]
The Brazilian and Italian study evaluating a tacrolimus-eluting stent with short-term dual antiplatelet therapy for stable and unstable coro…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions [NA]
A completed randomized trial comparing Limus Carbostent with Taxus DES in de novo coronary lesions.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS [NA]
Completed trial comparing neointimal coverage by optical coherence tomography between the CRE8 drug-eluting stent and a bare-metal stent in …
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel
A completed clinical trial compared ticagrelor against a very low-dose rivaroxaban regimen with clopidogrel in patients with Acute Coronary …